<DOC>
	<DOCNO>NCT02025335</DOCNO>
	<brief_summary>CMV one important opportunistic infection transplant recipient . In South Korea , 95 % adult reveal sero-positivity CMV IgG . Until , sero-positivity CMV IgG solid organ transplantation laboratory test choice stratify risk CMV reactivation solid organ transplantation . Theoretically , CMV-specific cell-mediate immune response solid organ transplantation categorize patient high low risk CMV development solid organ transplantation . The investigator thus evaluate usefulness CMV-specific ELISPOT assay kidney transplant candidate predict development CMV infection kidney transplantation .</brief_summary>
	<brief_title>Assessment CMV-specific ELISPOT Assay Predicting CMV Infection Kidney Transplant Recipients</brief_title>
	<detailed_description>Between Mar 2014 Mar 2015 , patient admit kidney transplant unit enrol study . All patient receive CMV-specific ELISPOT assay prospectively follow development CMV infection .</detailed_description>
	<mesh_term>Cytomegalovirus Infections</mesh_term>
	<criteria>age 16 agree write informed consent donor CMV IgG ( + ) recipient CMV IgG ( )</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>